Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 23, 2023

BUY
$191.51 - $216.16 $94,797 - $106,999
495 Added 1.37%
36,576 $7.76 Million
Q2 2023

Jul 24, 2023

BUY
$187.64 - $206.25 $3.12 Million - $3.43 Million
16,637 Added 85.56%
36,081 $6.94 Million
Q1 2023

May 03, 2023

SELL
$127.59 - $203.08 $4.92 Million - $7.83 Million
-38,559 Reduced 66.48%
19,444 $3.94 Million
Q4 2022

Feb 06, 2023

SELL
$117.37 - $139.17 $296,359 - $351,404
-2,525 Reduced 4.17%
58,003 $7.45 Million
Q3 2022

Dec 01, 2022

BUY
$135.27 - $180.11 $3.47 Million - $4.62 Million
25,654 Added 73.56%
60,528 $8.28 Million
Q3 2022

Oct 26, 2022

BUY
$135.27 - $180.11 $3.47 Million - $4.62 Million
25,654 Added 73.56%
60,528 $8.28 Million
Q2 2022

Dec 01, 2022

BUY
$108.81 - $179.33 $3.33 Million - $5.48 Million
30,562 Added 708.77%
34,874 $6.17 Million
Q2 2022

Jul 27, 2022

BUY
$108.81 - $179.33 $3.33 Million - $5.48 Million
30,562 Added 708.77%
34,874 $6.17 Million
Q1 2022

Dec 01, 2022

SELL
$119.61 - $157.85 $120,088 - $158,481
-1,004 Reduced 18.89%
4,312 $622,000
Q1 2022

Apr 26, 2022

SELL
$119.61 - $157.85 $120,088 - $158,481
-1,004 Reduced 18.89%
4,312 $622,000
Q4 2021

Dec 01, 2022

SELL
$142.57 - $190.86 $2 Million - $2.68 Million
-14,037 Reduced 72.53%
5,316 $821,000
Q4 2021

Jan 31, 2022

SELL
$142.57 - $190.86 $2 Million - $2.68 Million
-14,037 Reduced 72.53%
5,316 $821,000
Q3 2021

Dec 01, 2022

BUY
$142.45 - $169.82 $7,122 - $8,491
50 Added 0.26%
19,353 $3.29 Million
Q3 2021

Oct 20, 2021

BUY
$142.45 - $169.82 $7,122 - $8,491
50 Added 0.26%
19,353 $3.29 Million
Q2 2021

Dec 01, 2022

SELL
$135.08 - $161.1 $8.54 Million - $10.2 Million
-63,213 Reduced 76.61%
19,303 $3.05 Million
Q2 2021

Jul 28, 2021

SELL
$135.08 - $161.1 $8.54 Million - $10.2 Million
-63,213 Reduced 76.61%
19,303 $3.05 Million
Q1 2021

Dec 01, 2022

BUY
$137.51 - $190.8 $3.02 Million - $4.2 Million
21,988 Added 36.33%
82,516 $11.5 Million
Q1 2021

Apr 23, 2021

SELL
$137.51 - $190.8 $7.66 Million - $10.6 Million
-55,707 Reduced 40.3%
82,516 $11.5 Million
Q4 2020

Dec 01, 2022

BUY
$164.63 - $211.93 $12.8 Million - $16.5 Million
77,695 Added 128.36%
138,223 $24.2 Million
Q4 2020

Jan 28, 2021

BUY
$164.63 - $211.93 $22.8 Million - $29.3 Million
138,223 New
138,223 $24.2 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.